Clinical Trials Browser

Not yet recruiting × sintilimab × Breast × Clear all

NCT07254858 2025-11-28

CISN-L

Phase 2 Not yet recruiting

Breast Neoplasms

NCT06308939 2024-03-13

Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial

Phase 2 Not yet recruiting

Breast Neoplasms